跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 46 条关于
“RUNX1::RUNX1T1”
全部
46
临床试验
31
药物
4
机构
1
资讯
10
2年前
SJPedPanel: A Targeted Gene Panel for Enhanced Detection of Driver Alterations in Childhood Cancers
去年
CD19 CAR-T Cell Therapy Shows Promise in Relapsed t(8;21) AML Despite Short-Term Remission
去年
BTX A51 Shows Promise in Relapsed/Refractory AML with Notable Activity in RUNX1-Mutated Patients
19天前
Germline Variants Define Prognostic Subgroups in Therapy-Related Myeloid Neoplasms
去年
Real-World Study Reveals Persistent Gaps in Molecular Testing and Targeted Therapy Implementation for AML and MDS
去年
Non-ABL1 Mutations Impact Outcomes in Chronic Myeloid Leukemia
10个月前
SELLAS Life Sciences Reports Promising Phase 2 Results for SLS009 in Venetoclax-Resistant AML at ASH 2025
9个月前
VERONA Trial Shows Mixed Results for Venetoclax-Azacitidine Combination in High-Risk MDS
2个月前
AB Science's AB8939 Plus Venetoclax Achieves 67% ORR in Phase 1 Trial for High-Risk Relapsed/Refractory AML
上个月
Genomic Profiling of High-Risk Pediatric Tumors Reveals Actionable Alterations in Nearly One-Quarter of Patients